Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Schizophrenia: One Name, Many Different Manifestations
Justin Faden, Leslie Citrome
Medical Clinics of North America (2022) Vol. 107, Iss. 1, pp. 61-72
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Childhood Experiences of Individuals Whose Parents are Schizophrenia Patients: A Phenomenological Study
Nermin Kiliç, Hilal Seki Öz
International Journal of Systemic Therapy (2025), pp. 1-29
Closed Access
Effects of Lee Silverman Voice Treatment‐BIG on Motor, Cognition, Mental Health, Occupational Performance, and Occupational Balance in Patients With Schizophrenia: A Single‐Subject Experimental Study
Woo-Hyuk Jang, Sang-Min Seo, S.W. Kim
Occupational Therapy International (2025) Vol. 2025, Iss. 1
Open Access
Protein palmitoylation: biological functions, disease, and therapeutic targets
Yue-Wei Qian, Y Zhao, Feng Zhang
MedComm (2025) Vol. 6, Iss. 3
Open Access
ECT-induced primary open-angle glaucoma in a patient with unstable thyroid function: a case report
Chuancheng Fu, Xiuzhen Yang, Kun Li
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Current perspectives on the recognition and management of treatment-resistant schizophrenia: challenges and opportunities
Myrto Samara, Georgios Alevizopoulos, Vasilis P. Bozikasc, et al.
Expert Review of Neurotherapeutics (2025)
Closed Access
Identification of biomarkers related to propionate metabolism in schizophrenia
Wei Xie, Zhihong Luo, Jiang Xiao, et al.
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Epigenetics factors in schizophrenia: future directions for etiologic and therapeutic study approaches
Haidong Yang, Wenxi Sun, Liying Jin, et al.
Annals of General Psychiatry (2025) Vol. 24, Iss. 1
Open Access
Global research on cognitive function for Schizophrenia from 2014 to 2024: a bibliometric and visual analysis
Yixiang Gan, Dong Chun-yu, Jiaojiao Sun, et al.
Critical Public Health (2025) Vol. 35, Iss. 1
Open Access
The roles of extracellular vesicles in mental disorders: information carriers, biomarkers, therapeutic agents
Longkun Wang, Ruixue Liu, Ying Wang
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Association between elevated serum matrix metalloproteinase-2 and tumor necrosis factor-α, and clinical symptoms in male patients with treatment-resistant and chronic medicated schizophrenia
Haidong Yang, Ruijie Peng, Man Yang, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Natural Language Processing and Schizophrenia: A Scoping Review of Uses and Challenges
Antoine Deneault, Alexandre Dumais, Marie Désilets, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 7, pp. 744-744
Open Access | Times Cited: 3
Meta-analysis of structural and functional brain abnormalities in early-onset schizophrenia
Lu Wang, Ruishan Liu, Juan Liao, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 3
Reviewing Non-Dopaminergic Mechanisms for Positive and Negative Schizophrenia Symptom Management
Leslie Citrome, Jonathan M. Meyer
The Journal of Clinical Psychiatry (2023) Vol. 84, Iss. 4
Open Access | Times Cited: 8
Efficacy of HP-3070, A Once-Daily Asenapine Transdermal System, in the Treatment of Adults with Schizophrenia: A PANSS Five-Factor Analysis
Leslie Citrome, Mariacristina Castelli, Masami Hasebe, et al.
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 755-764
Open Access | Times Cited: 2
Immediate and delayed effects of environmental temperature on schizophrenia admissions in Liuzhou, China, 2013–2020: a time series analysis
Qian Zhou, Xiaolan Huang, Li Su, et al.
International Journal of Biometeorology (2024) Vol. 68, Iss. 5, pp. 843-854
Open Access | Times Cited: 1
Elucidating the molecular pharmacology of trace amine‐associated receptor 1 to advance antipsychotic drug discovery
Jingjing Yu, Zheng Xu, Wei Yan, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 1
Psychosocial and psychological interventions for schizophrenia relapse prevention: A bibliometric analysis
F. Liu, Wei Qiao, Xiuxia Yuan, et al.
Cambridge Prisms Global Mental Health (2024) Vol. 11
Open Access | Times Cited: 1
[Ursolic acid improved demyelination and interstitial fluid drainage disorders in schizophrenia mice].
Ren Long, Xin Mao, Tianzi Gao, et al.
PubMed (2024) Vol. 56, Iss. 3, pp. 487-494
Closed Access | Times Cited: 1
Global Prevalence of Metabolic Syndrome in Schizophrenia Patients: A Systematic Review and Meta-Analysis
Nader Salari, Nima Maghami, Theo Ammari, et al.
Journal of Prevention (2024) Vol. 45, Iss. 6, pp. 973-986
Closed Access | Times Cited: 1
Hyperactivity and Altered Functional Connectivity of the Ventral Striatum in Schizophrenia Compared with Bipolar Disorder: a resting state fMRI study
Li Zhang, Wenli Wang, Yuan Ruan, et al.
Psychiatry Research Neuroimaging (2024) Vol. 345, pp. 111881-111881
Closed Access | Times Cited: 1
Association between the levels of toxic heavy metals and schizophrenia in the population of Guangxi, China: A Case-Control Study
Bing Shen, Rumei Lu, Miao Lv, et al.
Environmental Pollution (2024), pp. 125179-125179
Closed Access | Times Cited: 1
Mitochondrial Dysfunction and Metabolic Indicators in Patients with Drug-Naive First-Episode Schizophrenia: A Case-Control Study
Haoran Chu, Houming Zhu, Jiashu Ma, et al.
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 2433-2442
Open Access | Times Cited: 1
Microglia and Other Cellular Mediators of Immunological Dysfunction in Schizophrenia: A Narrative Synthesis of Clinical Findings
Khoa D. Nguyen, Andrea Amerio, Andrea Aguglia, et al.
Cells (2023) Vol. 12, Iss. 16, pp. 2099-2099
Open Access | Times Cited: 3
The Influence of Electroconvulsive Therapy (ECT) on Brain-Derived Neurotrophic Factor (BDNF) Plasma Level in Patients with Schizophrenia—A Systematic Review and Meta-Analysis
Anna Maria Szota, Beata Kowalewska, Małgorzata Ćwiklińska‐Jurkowska, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 17, pp. 5728-5728
Open Access | Times Cited: 3
Second Generation Long-Acting Injectable Antipsychotics in Schizophrenia: The Patient’s Subjective Quality of Life, Well-Being, and Satisfaction
Claudio Brasso, Silvio Bellino, Paola Bozzatello, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 22, pp. 6985-6985
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top